Fukuda, Takeshi
Daiichi Sankyo Company, Limited,
Japan
2025 Rank: 28895
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Polymers
SubField 2:
Allergy
Rank in SubField 1: 245 out of 124976 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28895 | 26956 |
| Total Cites | 18174 | 21172 |
| H-index | 75 | 79 |
| Hm-index | 29 | 32 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 72 | 99 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 2291 | 2532 |
| Number of Single+First+Last Authored Papers | 272 | 272 |
| Total Cites to Single+First+Last Authored Papers | 11625 | 13200 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12503 | 13475 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.57 |
| Self-Citation Percentage |
14.16%
|
|
Fukuda, Takeshi
Daiichi Sankyo Company, Limited,
Japan
2024 Rank: 26900
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Polymers
SubField 2:
Allergy
Rank in SubField 1: 226 out of 116445 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26900 | 25343 |
| Total Cites | 17576 | 20483 |
| H-index | 74 | 78 |
| Hm-index | 29 | 31 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 72 | 98 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 2212 | 2444 |
| Number of Single+First+Last Authored Papers | 268 | 268 |
| Total Cites to Single+First+Last Authored Papers | 11247 | 12775 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12106 | 13047 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.57 |
| Self-Citation Percentage |
14.19%
|
|
Fukuda, Takeshi
Tochigi Medical Center Shimotsuga,
Japan
2023 Rank: 25164
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Polymers
SubField 2:
Allergy
Rank in SubField 1: 224 out of 108979 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25164 | 23326 |
| Total Cites | 17099 | 19964 |
| H-index | 72 | 77 |
| Hm-index | 29 | 31 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 71 | 97 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 2182 | 2414 |
| Number of Single+First+Last Authored Papers | 268 | 268 |
| Total Cites to Single+First+Last Authored Papers | 10978 | 12478 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11714 | 12642 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.58 |
| Self-Citation Percentage |
14.35%
|
|
Fukuda, Takeshi
Dokkyo Medical University,
Japan
2020 Rank: 19187
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Polymers
SubField 2:
Allergy
Rank in SubField 1: 163 out of 80670 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19187 | 18304 |
| Total Cites | 15421 | 18082 |
| H-index | 71 | 76 |
| Hm-index | 27 | 30 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 74 | 89 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 2125 | 2393 |
| Number of Single+First+Last Authored Papers | 218 | 218 |
| Total Cites to Single+First+Last Authored Papers | 9622 | 10945 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 10810 | 11796 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.53 |
| Self-Citation Percentage |
14.72%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.